Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.

The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...

Full description

Saved in:
Bibliographic Details
Main Authors: Harris, A. L., Dowsett, M., Smith, I. E., Jeffcoate, S. L.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1983
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2011397/
https://ncbi.nlm.nih.gov/pubmed/6221746
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items